Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Swati Gupta, Yashwant Pathak, Manish K. Gupta & Suresh P. Vyas. (2019) RETRACTED ARTICLE: Nanoscale drug delivery strategies for therapy of ovarian cancer: conventional vs targeted. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 4066-4088.
Read now
Read now
Shahrooz Saremi, Fatemeh Atyabi, Seyedeh Parinaz Akhlaghi, Seyed Nasser Ostad & Rassoul Dinarvand. (2011) Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation. International Journal of Nanomedicine 6, pages 119-128.
Read now
Read now
Ahmad Awada, Steven Zhang, Thierry Gil, Dominique de Valeriola, Yassine Lalami, Peter De Porre & Martine J. Piccart-Gebhart. (2007) A phase I clinical and pharmacokinetic study of tipifarnib in combination with docetaxel in patients with advanced solid malignancies. Current Medical Research and Opinion 23:5, pages 991-1003.
Read now
Read now
Articles from other publishers (15)
Bin Lai, Xi Ouyang, Shengxun Mao, Jiaqin Cao, Honglang Li, Song Li & Jiwei Wang. (2023) Target tumor therapy in human gastric cancer cells through the combination of docetaxel-loaded cationic lipid microbubbles and ultrasound-triggered microbubble destruction. Functional & Integrative Genomics 23:1.
Crossref
Crossref
Yue Hou, Chunru Zhao, Binglin Xu, Yuxi Huang & Chuanzhi Liu. (2021) Effect of docetaxel on mechanical properties of ovarian cancer cells. Experimental Cell Research 408:1, pages 112853.
Crossref
Crossref
Xiang Gao, Shimin Wang, BiLan Wang, Senyi Deng, Xiaoxiao Liu, XiaoNing Zhang, LinLi Luo, RangRang Fan, MingLi Xiang, Chao You, YuQuan Wei, ZhiYong Qian & Gang Guo. (2015) Improving the anti-ovarian cancer activity of docetaxel with biodegradable self-assembly micelles through various evaluations. Biomaterials 53, pages 646-658.
Crossref
Crossref
Ai-ting Wang, De-sheng Liang, Yu-jie Liu & Xian-rong Qi. (2015) Roles of ligand and TPGS of micelles in regulating internalization, penetration and accumulation against sensitive or resistant tumor and therapy for multidrug resistant tumors. Biomaterials 53, pages 160-172.
Crossref
Crossref
Joseph A. Reddy, Ryan Dorton, Alicia Bloomfield, Melissa Nelson, Marilynn Vetzel, John Guan & Christopher P. Leamon. (2014) Rational Combination Therapy of Vintafolide (EC145) with Commonly Used Chemotherapeutic Drugs. Clinical Cancer Research 20:8, pages 2104-2114.
Crossref
Crossref
Nickholas Zhidkov, Raquel De Souza, Amir H. Ghassemi, Christine Allen & Micheline Piquette-Miller. (2013) Continuous Intraperitoneal Carboplatin Delivery for the Treatment of Late-Stage Ovarian Cancer. Molecular Pharmaceutics 10:9, pages 3315-3322.
Crossref
Crossref
Chengfei Liu, Yezi Zhu, Wei Lou, Nagalakshmi Nadiminty, Xinbin Chen, Qinghua Zhou, Xu Bao Shi, Ralph W. deVere White & Allen C. Gao. (2012) Functional p53 determines docetaxel sensitivity in prostate cancer cells. The Prostate 73:4, pages 418-427.
Crossref
Crossref
Sagar Dhamne, Robert E. Brown, Michael Covinsky, Chetan Dhamne, Karen Eldin & Nina Tatevian. (2015) Clear Cell Sarcoma of Kidney: Morphoproteomic Analysis Reveals Genomic Correlates and Therapeutic Options. Pediatric and Developmental Pathology 16:1, pages 20-27.
Crossref
Crossref
Shahrooz Saremi, Rassoul Dinarvand, Abbas Kebriaeezadeh, Seyed Nasser Ostad & Fatemeh Atyabi. (2013) Enhanced Oral Delivery of Docetaxel Using Thiolated Chitosan Nanoparticles: Preparation, In Vitro and In Vivo Studies. BioMed Research International 2013, pages 1-8.
Crossref
Crossref
Julie Tomasina, Stéphanie Lheureux, Pascal Gauduchon, Sylvain Rault & Aurélie Malzert-Fréon. (2013) Nanocarriers for the targeted treatment of ovarian cancers. Biomaterials 34:4, pages 1073-1101.
Crossref
Crossref
Julie A. DeLoia, Nikhil R. Bhagwat, Kathleen M. Darcy, Mary Strange, Chunquio Tian, Kevin Nuttall, Thomas C. Krivak & Laura J. Niedernhofer. (2012) Comparison of ERCC1/XPF genetic variation, mRNA and protein levels in women with advanced stage ovarian cancer treated with intraperitoneal platinum. Gynecologic Oncology 126:3, pages 448-454.
Crossref
Crossref
Preetinder P Singh, Swapna Joshi, Pamela J Russell, Sham Nair & Aparajita Khatri. (2011) Purine Nucleoside Phosphorylase mediated molecular chemotherapy and conventional chemotherapy: A tangible union against chemoresistant cancer. BMC Cancer 11:1.
Crossref
Crossref
Wei Jin, Lin Cai, Guangfeng Niu & Hai Tao. (2009) Proliferation inhibition effect of docetaxel combined with cisplatin on osteosarcoma cells. Medical Oncology 27:2, pages 491-494.
Crossref
Crossref
Qamar Ghafoor & Anula Chetiyawardana. (2008) Nail changes secondary to docetaxel chemotherapy : a case report. Journal of Medical Case Reports 2:1.
Crossref
Crossref
Berta Otová, Radka Václavíková, Vlasta Danielová, Jaroslava Holubová, Marie Ehrlichová, Stanislav Horský, Pavel Souček, Petr Šimek & Ivan Gut. (2006) Effects of paclitaxel, docetaxel and their combinations on subcutaneous lymphomas in inbred Sprague–Dawley/Cub rats. European Journal of Pharmaceutical Sciences 29:5, pages 442-450.
Crossref
Crossref